VIBRA SPECIALTY HOSP PORTLAND
1. Target Overview & Investment Thesis
VIBRA SPECIALTY HOSP PORTLAND is a 73-bed community hospital in MULTNOMAH, OR with $30.0M in net patient revenue and a -33.1% operating margin. The hospital serves a payer mix of 22.8% Medicare, 0.0% Medicaid, and 77.2% commercial.
Thesis: Turnaround. Our ML models identify $2.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -33.1% to -25.8% (+736bps).
| Net Revenue HCRIS | $30.0M |
| Current EBITDA COMPUTED | $-9.9M |
| Operating Margin COMPUTED | -33.1% |
| Occupancy HCRIS | 69.1% |
| Revenue / Bed COMPUTED | $411K |
| Net-to-Gross HCRIS | 16.2% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
OR has 63 Medicare-certified hospitals with a median operating margin of -8.1%. The target's margin of -33.1% places it below the state median. Among 19 size-comparable peers (36-146 beds), the median margin is -10.9%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (36-146), prioritizing same-state peers. 19 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| VIBRA SPECIALTY HOSP PORTLAND (Target) | OR | 73 | $30.0M | -33.1% |
| TUALITY HEALTHCARE | OR | 113 | $268.5M | -13.1% |
| LEGACY MERIDIAN PARK HOSPITAL | OR | 123 | $265.2M | -0.4% |
| THREE RIVERS MEDICAL CENTER | OR | 142 | $252.5M | -12.4% |
| SKY LAKES MEDICAL CENTER | OR | 90 | $251.4M | -20.9% |
| MCKENZIE-WILLAMETTE HOSPITAL | OR | 113 | $247.7M | -2.6% |
| MERCY MEDICAL CENTER | OR | 130 | $247.1M | -2.1% |
| PROVIDENCE MEDFORD MEDICAL CEN | OR | 96 | $239.8M | -17.3% |
| SAMARITAN ALBANY GENERAL HOSPI | OR | 67 | $220.1M | -12.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.2M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $629K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $599K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $593K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $365K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $19K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-9.9M |
| + RCM Uplift | +$2.2M |
| Pro Forma EBITDA | $-7.7M |
| Current Margin | -33.1% |
| Pro Forma Margin | -25.8% |
| WC Released (1x) | $1.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-15.3M | $-43.4M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-15.3M | $-52.7M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-13.7M | $-50.4M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-13.7M | $-59.0M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-16.8M | $-49.5M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-16.8M | $-59.9M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 19 hospitals with 36-146 beds
- Same-state prioritization (n=20)
- Comp margins: P25=-13.7% / P50=-10.9% / P75=-2.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.